Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4531 AL 4545

Multiple Targets for the Management of Alzheimer's Disease

Ahmad SS, Akhtar S, Jamal QM, Rizvi SM, Kamal MA, Khan MK, Siddiqui MH.

CNS Neurol Disord Drug Targets. 2016;15(10):1279-1289. doi: 10.2174/1871527315666161003165855.

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.

Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1.

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease

Deardorff WJ, Grossberg GT.

Drug Des Devel Ther. 2016 Oct 3;10:3267-3279. doi: 10.2147/DDDT.S86463. eCollection 2016.

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM.

Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.

[Effectiveness of non-pharmacological interventions in the quality of life of caregivers of Alzheimer]

Amador-Marín B, Guerra-Martín MD.

Gac Sanit. 2017 Mar-Apr;31(2):154-160. doi: 10.1016/j.gaceta.2016.09.006. Epub 2016 Nov 22.

Alzheimer's disease: expedition into the unknown

The Lancet.

Lancet. 2016 Dec 3;388(10061):2713. doi: 10.1016/S0140-6736(16)32457-6. Epub 2016 Dec 2.

Effect of galantamine on attention in patients with Alzheimer's disease combined with cerebrovascular disease

Park JJ, Choi SH, Kim S, Lee AY, Moon SY, Lee JH, Kwon JC, Park KW, Ku BD, Han HJ, Kim EJ, Shim YS.

Geriatr Gerontol Int. 2017 Oct;17(10):1661-1666. doi: 10.1111/ggi.12934. Epub 2016 Dec 9.

African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation

Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.

Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.

[Non-pharmacological treatment of dementia in geriatric psychiatry care units : Scoping review]

Göhner A, Hüll M, Voigt-Radloff S.

Z Gerontol Geriatr. 2018 Feb;51(2):169-183. doi: 10.1007/s00391-016-1161-7. Epub 2016 Dec 16.

Special Issue: "Molecules against Alzheimer"

Decker M, Muñoz-Torrero D.

Molecules. 2016 Dec 16;21(12):1736. doi: 10.3390/molecules21121736.

Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results

Lee KJ, Cho SJ, Kim BC, Park M, Lee JH.

Adv Ther. 2017 Feb;34(2):481-494. doi: 10.1007/s12325-016-0465-8. Epub 2016 Dec 20.

Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy

Phillips C, Fahimi A, Das D, Mojabi FS, Ponnusamy R, Salehi A.

Curr Alzheimer Res. 2016;13(1):68-83. doi: 10.2174/1567205012666150921095924.

[Cognitive rehabilitation in early stage Alzheimer's disease]

Kasper E, Thöne-Otto A, Bürger K, Schröder SG, Hoffmann W, Schneider W, Teipel S.

Nervenarzt. 2016 Jul;87(7):708-18. doi: 10.1007/s00115-015-4426-2.

Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome

Giulietti A, Vignini A, Nanetti L, Mazzanti L, Di Primio R, Salvolini E.

Curr Neuropharmacol. 2016;14(2):177-90. doi: 10.2174/1570159x13666150928155321.

Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia

Ashraf GM, Chibber S, Mohammad, Zaidi SK, Tabrez S, Ahmad A, Shakil S, Mushtaq G, Baeesa SS, Kamal MA.

Med Chem. 2016;12(3):226-37. doi: 10.2174/1573406411666151030111820.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias